Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tapestry
TPR
|
+$14.4M |
| 2 |
CNVR
CONVERSANT INC COM STK (DE)
CNVR
|
+$13.9M |
| 3 |
Pilgrim's Pride
PPC
|
+$12.6M |
| 4 |
WW
WW International
WW
|
+$12.1M |
| 5 |
URS
URS CORP
URS
|
+$11.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$26.5M |
| 2 |
GameStop
GME
|
+$16.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$15.1M |
| 4 |
Jabil
JBL
|
+$11.5M |
| 5 |
SGI
Somnigroup International
SGI
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.74% |
| 2 | Technology | 18.13% |
| 3 | Consumer Discretionary | 17.87% |
| 4 | Healthcare | 10.98% |
| 5 | Consumer Staples | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $29.8M | 0.97% |
177,321
-90,121
| -34% | -$15.1M |
|
2
United Therapeutics
UTHR
$22B
| $29.3M | 0.95% |
372,147
+30,817
| +9% | +$2.25M |
|
|
ATVI
3
DELISTED
Activision Blizzard
ATVI
| $24.4M | 0.79% |
1,464,965
+242,309
| +20% | +$4.01M |
|
|
ENDP
4
DELISTED
Endo International plc
ENDP
| $23.7M | 0.77% |
521,987
+81,497
| +19% | +$3.28M |
|
|
WCRX
5
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
| $23.5M | 0.76% |
1,026,192
-198,437
| -16% | -$4.2M |
|
|
PDLI
6
DELISTED
PDL BioPharma, Inc.
PDLI
| $23M | 0.75% |
2,890,564
+575,183
| +25% | +$4.62M |
|
7
Myriad Genetics
MYGN
$306M
| $22.7M | 0.74% |
965,987
+413,312
| +75% | +$11.7M |
|
8
Altria Group
MO
$110B
| $22.5M | 0.73% |
656,458
+216,528
| +49% | +$7.63M |
|
|
9
Tapestry
TPR
$26B
| $21.8M | 0.71% |
400,563
+262,103
| +189% | +$14.4M |
|
10
Deluxe
DLX
$1.08B
| $21.8M | 0.71% |
523,682
+49,386
| +10% | +$1.98M |
|
11
Cisco
CSCO
$438B
| $21.6M | 0.7% |
921,316
+278,015
| +43% | +$6.9M |
|
12
Booz Allen Hamilton
BAH
$9.27B
| $21.5M | 0.7% |
1,110,651
+155,486
| +16% | +$3.04M |
|
13
Apple
AAPL
$4.51T
| $19.9M | 0.65% |
1,169,112
+57,316
| +5% | +$950K |
|
|
WW
14
DELISTED
WW International
WW
| $19.3M | 0.63% |
516,705
+299,517
| +138% | +$12.1M |
|
15
Northrop Grumman
NOC
$78.3B
| $18M | 0.59% |
189,161
+6,226
| +3% | +$575K |
|
16
CACI
CACI
$14.3B
| $17.9M | 0.58% |
258,356
+17,854
| +7% | +$1.19M |
|
|
LO
17
DELISTED
LORILLARD INC COM STK
LO
| $17.6M | 0.57% |
392,020
+88,560
| +29% | +$3.9M |
|
|
CNVR
18
DELISTED
CONVERSANT INC COM STK (DE)
CNVR
| $17.4M | 0.57% |
836,536
+610,892
| +271% | +$13.9M |
|
19
Chemed
CHE
$7.07B
| $17.4M | 0.57% |
243,527
+93,804
| +63% | +$6.67M |
|
|
RTN
20
DELISTED
Raytheon Company
RTN
| $17.4M | 0.57% |
225,809
-30,994
| -12% | -$2.3M |
|
21
Oracle
ORCL
$422B
| $16.9M | 0.55% |
509,246
+234,952
| +86% | +$7.62M |
|
22
L3Harris
LHX
$49.7B
| $16.6M | 0.54% |
280,019
+68,255
| +32% | +$3.8M |
|
23
Western Union
WU
$2.28B
| $16.2M | 0.53% |
870,591
-35,526
| -4% | -$638K |
|
24
Microsoft
MSFT
$3.59T
| $16M | 0.52% |
480,884
+112,224
| +30% | +$3.69M |
|
25
Valmont Industries
VMI
$9.38B
| $15.5M | 0.5% |
111,416
+61,432
| +123% | +$8.78M |
|
Similar funds
Joel Greenblatt's Q3 2013 Portfolio in Review
As of Q3 2013, Joel Greenblatt held 1,022 positions worth $3.08B, up 32% from $2.33B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Joel Greenblatt deployed $539M of net new capital in Q3 2013, opening 183 new positions and adding to 402 existing holdings. Its largest new stake was Pilgrim's Pride: 761,966 shares worth $12.8M.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Wells Fargo, an estimated $26.5M trimmed.
- Joel Greenblatt's largest Q3 2013 buy was Pilgrim's Pride: 761,966 shares worth $12.8M.
- Joel Greenblatt added most to Tapestry in Q3 2013, an estimated $14.4M increase.
- Joel Greenblatt's biggest Q3 2013 reduction was Wells Fargo, cutting an estimated $26.5M.
- Joel Greenblatt fully exited SALIX PHARMACEUTICALS LTD DEL in Q3 2013, selling an estimated $8.43M.
- Joel Greenblatt's ten largest holdings make up 7.9% of its $3.08B portfolio in Q3 2013.
- Joel Greenblatt opened 183 new positions and closed 141 in Q3 2013.
- Joel Greenblatt's portfolio value rose 32% quarter-over-quarter to $3.08B.
Based on Gotham Asset Management's 13F filing for Q3 2013, filed 14 Nov 2013.